The effect of methylprednisolone on proliferation of PBMCs obtained from steroid‐sensitive and steroid‐resistant rheumatoid arthritis patients

References

• Hench P., Kendall S. C., Slocumb C. H., Polley H. F. The effects of the hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Mayo Clin 1949; 24: 181–3
   PubMed Web of Science ®Google Scholar
• van Schaardenburg D., Valkema R., Dijkmans B. A., Papapoulos S., Zwinderman A. H., Han K. H., et al. Prednisone treatment of elderly‐onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis Rheum 1995; 38: 334–42
   PubMed Web of Science ®Google Scholar
• Seki M., Ushiyama C., Seta N., Abe K., Fukazawa T., Asakawa J., et al. Apoptosis in lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 823–30
   PubMedGoogle Scholar
• Szefler S. J., Martin R. J., King T. S., Boushey H. A., Cherniack R. M., Chinchilli V. M., et al. Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2005; 115: 466–9
   PubMedGoogle Scholar
• Honda M., Orii F., Ayabe T., Imai S., Ashida T., Obara T., et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid resistant ulcerative colitis. Gastroenterology 2000; 118: 859–66
   PubMed Web of Science ®Google Scholar
• Goulding N. J., Podgorski M. R., Hall N. D., Flower R. J., Browning J. L., et al. Autoantibodies to recombinant lipocortin‐1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 843–50
   PubMed Web of Science ®Google Scholar
• Druilhe A., Letuve S., Pretolani M. Glucocorticoid‐induced apoptosis in human eosinophils: mechanism of action. Apoptosis 2003; 8: 481–95
   PubMed Web of Science ®Google Scholar
• Raddatz D., Middel P., Bockemuhl M., Benohr P., Wissmann C., Schworer H., et al. Glucocorticoid receptor expression in inflammatory bowel disease: evidence for mucosal down‐regulation in steroid‐unresponsive ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 47–61
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• van Gestel A. M., Prevoo M. L., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39: 34–40
   PubMed Web of Science ®Google Scholar
• Schwartz H. J., Lowell F. C., Melby J. C. Steroid resistance in bronchial asthma. Ann Intern Med 1968; 69: 493–9
   PubMedGoogle Scholar
• Hirara F., Del Carmine R., Nelson C. A. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin in patients with rheumatic diseases. Proc Natl Acad Sci USA 1981; 78: 3190–4
   PubMedGoogle Scholar
• Kay A. B., Diaz P., Carmichael J., Grant I. W. B. Corticosteroid resistant chronic asthma and monocyte complement receptors. Clin Exp Immunol 1981; 44: 576–80
   PubMed Web of Science ®Google Scholar
• Takahashi E., Onda K., Hirano T., Oka K., Maruoka N., Tsuyuguchi M., et al. Expression c‐fos, rather than c‐jun or glucocorticoid‐receptor mRNA, correlates with decreased glucocorticoid response of peripheral blood mononuclear cells in asthma. Int Immunopharmacol 2002; 10: 1419–27
   Google Scholar
• Chicanza I. C. Mechanisms of corticosteroid resistance in rheumatoid arthritis: a putative role for the corticosteroid receptor beta isoform. Ann N Y Acad Sci 2002; 966: 36–48
   Google Scholar
• Adcock M., Lane S. J., Lee T. H., Barnes P. J. AP‐1 and glucocorticoid receptor DNA binding in peripheral blood mononuclear cells from steroid sensitive and resistant patients. Am J Respir Crit Care Med 1995; 151: A391–4
   Google Scholar
• Buttgereit F., Saag K. G., Cutolo M., da Silva J. A. P., Bijlsma J. W. J. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 2005; 34: 14–21
   PubMed Web of Science ®Google Scholar
• Tohyama C. T., Yamakawa M., Murasawa A., Nakazono K., Ishikawa H. Localization of human glucocorticoid receptor in rheumatoid synovial tissue of the knee joint. Scand J Rheumatol 2005; 34: 426–32
   PubMed Web of Science ®Google Scholar
• Dilger K., Cascorbi I., Grunhage F., Hohenester S., Sauerbruch T., Beuers U. Multidrug resistance 1 genotype and disposition of budesonide in early primary bilary cirrhosis. Liver Int 2006; 26: 285–290
   PubMedGoogle Scholar
• Pelletier J‐P., Dibattista J. A., Ranger P., Martel‐Pelletier J. The reduced expression of glucocorticoid receptors in synovial cells induced by nonsteroidal antiinflammatory drugs can be reversed by prostaglandin E1 analog. J Rheumatol 1994; 21: 1748–52
   PubMedGoogle Scholar
• Uribe M., Casian C., Rojas S., Sierra J. G., Go V. L. W. Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers. Gastroenterology 1981; 80: 661–5
   PubMedGoogle Scholar
• Picard D., Yamamoto K. R. Two signals mediate hormone dependent nuclear localisation of the glucocorticoid receptor. EMBO J 1987; 6: 3333–40
   PubMed Web of Science ®Google Scholar
• Frey F. J., Horber F. F., Frey B. M. Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism. Clin Pharmacol Ther 1988; 44: 510–21
   PubMedGoogle Scholar
• Barnes P. J., Grening A. P., Crompton G. K. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995; 152: S125–40
   PubMed Web of Science ®Google Scholar
• Harris E. D., Emkey R. D., Nichols J. E. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983; 10: 713–21
   PubMed Web of Science ®Google Scholar
• Lacki J. K., Leszczynski P., Mackiewicz S. H. Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis. The effect on lymphocytes. J Invest Allergy Clin Immunol 1996; 6: 232–6
   PubMed Web of Science ®Google Scholar
• Mc Dougall R., Sibley J., Haga M., Russell A. Outcome in patients with rheumatoid arthritis receiving prednisolone compared to matched controls. J Rheumatol 1994; 21: 1207–13
   PubMedGoogle Scholar
• van Gestel A. M., Laan R. F. M., Haagsma C. J., van de Putte L. B. A., van Riel P. L. C. M. Oral steroid as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomised double blind placebo controlled trial. Br J Rheumatol 1995; 34: 347–51
   PubMedGoogle Scholar
• Sauer J., Polack E., Wikinski S., Holsboer F., Stalla G. K., Arzt E. The glucocorticoid sensitivity of lymphocytes changes according to the activity of the hypothalamic–pituitary–adrenocortical system. Psychoneuroendocrinology 1995; 20: 269–80
   PubMed Web of Science ®Google Scholar
• Schlaghecke R., Beuscher D., Kornely E., Specker C. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum 1994; 37: 1127–31
   PubMedGoogle Scholar
• Messner R. P. Clinical aspects of T‐ and B‐lymphocytes in rheumatic diseases. Arthritis Rheum 1974; 17: 339–46
   PubMedGoogle Scholar
• Corrigan C. J., Brown P. H., Barnes N. C., Tsai J. J., Frew A. J., Kay A. B. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Resp Dis 1991; 144: 1026–32
   PubMedGoogle Scholar
• Poznansky M. C., Gordon A. C., Douglas J. G., Krajewski A. S., Wyllie A. H., Grant I. W. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid‐resistant asthmatic patients. Clin Sci 1984; 67: 639–45
   PubMed Web of Science ®Google Scholar